<!-- Visualization: HRT Decision Framework -->
<!-- Generated: 2025-12-23 -->
<!-- Type: interactive-flowchart -->
<!-- Source: Multiple clinical guidelines -->

<figure class="data-viz" id="viz-7">
  <div class="viz-container">
    <h3 class="framework-title">HRT Decision Framework: Is Hormone Therapy Right for You?</h3>

    <div class="decision-flow">
      <!-- Step 1: Age/Timing -->
      <div class="decision-step" id="step-timing">
        <div class="step-number">1</div>
        <div class="step-content">
          <h4>Timing Assessment</h4>
          <p>Are you under 60 years old OR within 10 years of menopause?</p>
          <div class="answer-boxes">
            <div class="answer-box yes">
              <span class="answer-icon">&#x2705;</span>
              <span>YES</span>
              <span class="answer-note">Favorable timing window</span>
            </div>
            <div class="answer-box caution">
              <span class="answer-icon">&#x26A0;</span>
              <span>NO</span>
              <span class="answer-note">Higher risk, consider alternatives</span>
            </div>
          </div>
        </div>
      </div>

      <div class="flow-arrow">&#x2193;</div>

      <!-- Step 2: Symptoms -->
      <div class="decision-step" id="step-symptoms">
        <div class="step-number">2</div>
        <div class="step-content">
          <h4>Symptom Evaluation</h4>
          <p>Do you have moderate to severe menopausal symptoms?</p>
          <div class="symptom-list">
            <span class="symptom">Hot flashes</span>
            <span class="symptom">Night sweats</span>
            <span class="symptom">Vaginal dryness</span>
            <span class="symptom">Sleep disturbances</span>
            <span class="symptom">Mood changes</span>
          </div>
          <div class="answer-boxes">
            <div class="answer-box yes">
              <span>YES - HRT most effective treatment</span>
            </div>
            <div class="answer-box maybe">
              <span>Mild symptoms - consider alternatives first</span>
            </div>
          </div>
        </div>
      </div>

      <div class="flow-arrow">&#x2193;</div>

      <!-- Step 3: Contraindications -->
      <div class="decision-step contraindications" id="step-contra">
        <div class="step-number">3</div>
        <div class="step-content">
          <h4>Contraindication Check</h4>
          <p>Do you have any of these conditions?</p>
          <div class="contra-grid">
            <div class="contra-item absolute">
              <strong>AVOID HRT:</strong>
              <ul>
                <li>History of breast cancer</li>
                <li>Active blood clot or PE</li>
                <li>History of stroke or heart attack</li>
                <li>Active liver disease</li>
                <li>Undiagnosed vaginal bleeding</li>
              </ul>
            </div>
            <div class="contra-item caution">
              <strong>CAREFUL EVALUATION:</strong>
              <ul>
                <li>Cardiovascular disease</li>
                <li>High CV risk (>10% 10-year)</li>
                <li>Family history breast cancer</li>
                <li>Thrombophilia</li>
                <li>Migraine with aura</li>
              </ul>
            </div>
          </div>
        </div>
      </div>

      <div class="flow-arrow">&#x2193;</div>

      <!-- Step 4: Route Selection -->
      <div class="decision-step" id="step-route">
        <div class="step-number">4</div>
        <div class="step-content">
          <h4>Route of Administration</h4>
          <div class="route-grid">
            <div class="route-option transdermal">
              <h5>&#x1FA79; Transdermal (Preferred for most)</h5>
              <p>Patches, gels, sprays</p>
              <ul>
                <li>No VTE risk increase</li>
                <li>Lower stroke risk</li>
                <li>Lower doses effective</li>
              </ul>
              <p class="best-for"><strong>Best for:</strong> VTE risk factors, obesity, smokers, age >60</p>
            </div>
            <div class="route-option oral">
              <h5>&#x1F48A; Oral</h5>
              <p>Pills, tablets</p>
              <ul>
                <li>Convenient</li>
                <li>Better HDL effects</li>
                <li>Higher VTE risk</li>
              </ul>
              <p class="best-for"><strong>Best for:</strong> Low-risk women, younger patients</p>
            </div>
            <div class="route-option vaginal">
              <h5>&#x1F489; Vaginal (Local)</h5>
              <p>Creams, rings, tablets</p>
              <ul>
                <li>Minimal systemic effects</li>
                <li>No VTE risk</li>
                <li>GSM symptoms only</li>
              </ul>
              <p class="best-for"><strong>Best for:</strong> GSM only, breast cancer survivors (with guidance)</p>
            </div>
          </div>
        </div>
      </div>

      <div class="flow-arrow">&#x2193;</div>

      <!-- Step 5: Type -->
      <div class="decision-step" id="step-type">
        <div class="step-number">5</div>
        <div class="step-content">
          <h4>Therapy Type</h4>
          <div class="type-grid">
            <div class="type-option">
              <h5>Had Hysterectomy?</h5>
              <div class="type-arrow">&#x2192;</div>
              <div class="type-result">
                <strong>Estrogen-Only</strong>
                <p>Lower breast cancer risk (23% reduction)</p>
              </div>
            </div>
            <div class="type-option">
              <h5>Uterus Intact?</h5>
              <div class="type-arrow">&#x2192;</div>
              <div class="type-result">
                <strong>Combined (E + P)</strong>
                <p>Consider micronized progesterone over synthetic progestins for lower breast cancer risk</p>
              </div>
            </div>
          </div>
        </div>
      </div>

      <div class="flow-arrow final">&#x2193;</div>

      <!-- Final -->
      <div class="decision-final">
        <h4>&#x1F4AC; Discuss with Your Healthcare Provider</h4>
        <p>This framework provides guidance, but individual decisions should be made with a healthcare provider who can assess your complete medical history, current health status, and personal preferences.</p>
        <p class="annual-review">&#x1F4C5; Annual review recommended to reassess benefits and risks</p>
      </div>
    </div>
  </div>
  <figcaption>
    <strong>Figure 7:</strong> Evidence-based decision framework for hormone replacement therapy. This flowchart synthesizes current clinical guidelines to help women and healthcare providers navigate the HRT decision process. Individual circumstances always require personalized medical assessment.
    <span class="viz-source">Sources: ACOG, The Menopause Society, AHA Scientific Statement, NHS Guidelines</span>
  </figcaption>
</figure>

<style>
.data-viz {
  margin: 2rem 0;
  padding: 1.5rem;
  background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
  border-radius: 12px;
  box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.framework-title {
  text-align: center;
  color: #1e293b;
  font-size: 1.5rem;
  margin-bottom: 1.5rem;
  padding-bottom: 1rem;
  border-bottom: 2px solid #e2e8f0;
}

.decision-flow {
  max-width: 900px;
  margin: 0 auto;
}

.decision-step {
  display: flex;
  gap: 1rem;
  background: white;
  padding: 1.25rem;
  border-radius: 12px;
  box-shadow: 0 1px 3px rgba(0,0,0,0.1);
  margin-bottom: 0.5rem;
}

.step-number {
  width: 40px;
  height: 40px;
  background: linear-gradient(135deg, #3b82f6 0%, #1d4ed8 100%);
  color: white;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  font-size: 1.1rem;
  flex-shrink: 0;
}

.step-content {
  flex: 1;
}

.step-content h4 {
  margin: 0 0 0.5rem 0;
  color: #1e293b;
  font-size: 1.1rem;
}

.step-content p {
  margin: 0 0 0.75rem 0;
  color: #475569;
}

.answer-boxes {
  display: flex;
  gap: 1rem;
  flex-wrap: wrap;
}

.answer-box {
  padding: 0.75rem 1rem;
  border-radius: 8px;
  display: flex;
  flex-direction: column;
  align-items: center;
  gap: 0.25rem;
  font-weight: 600;
  font-size: 0.9rem;
}

.answer-box.yes {
  background: #dcfce7;
  border: 2px solid #22c55e;
  color: #166534;
}

.answer-box.caution {
  background: #fef3c7;
  border: 2px solid #f59e0b;
  color: #92400e;
}

.answer-box.maybe {
  background: #e0e7ff;
  border: 2px solid #6366f1;
  color: #3730a3;
}

.answer-icon {
  font-size: 1.25rem;
}

.answer-note {
  font-weight: 400;
  font-size: 0.8rem;
}

.flow-arrow {
  text-align: center;
  font-size: 1.5rem;
  color: #94a3b8;
  padding: 0.25rem 0;
}

.flow-arrow.final {
  color: #3b82f6;
}

.symptom-list {
  display: flex;
  flex-wrap: wrap;
  gap: 0.5rem;
  margin-bottom: 0.75rem;
}

.symptom {
  background: #e0e7ff;
  color: #3730a3;
  padding: 0.25rem 0.75rem;
  border-radius: 20px;
  font-size: 0.85rem;
}

.contra-grid {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
  gap: 1rem;
  margin-top: 0.5rem;
}

.contra-item {
  padding: 1rem;
  border-radius: 8px;
}

.contra-item.absolute {
  background: #fef2f2;
  border-left: 4px solid #ef4444;
}

.contra-item.caution {
  background: #fef3c7;
  border-left: 4px solid #f59e0b;
}

.contra-item strong {
  display: block;
  margin-bottom: 0.5rem;
  font-size: 0.85rem;
}

.contra-item.absolute strong { color: #b91c1c; }
.contra-item.caution strong { color: #92400e; }

.contra-item ul {
  margin: 0;
  padding-left: 1.25rem;
  font-size: 0.85rem;
  color: #475569;
}

.contra-item li {
  margin-bottom: 0.25rem;
}

.route-grid {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
  gap: 1rem;
  margin-top: 0.5rem;
}

.route-option {
  padding: 1rem;
  border-radius: 8px;
  border: 2px solid;
}

.route-option.transdermal {
  background: #f0fdf4;
  border-color: #22c55e;
}

.route-option.oral {
  background: #fef3c7;
  border-color: #f59e0b;
}

.route-option.vaginal {
  background: #e0e7ff;
  border-color: #6366f1;
}

.route-option h5 {
  margin: 0 0 0.5rem 0;
  font-size: 0.95rem;
}

.route-option p {
  margin: 0 0 0.5rem 0;
  font-size: 0.85rem;
  color: #64748b;
}

.route-option ul {
  margin: 0;
  padding-left: 1.25rem;
  font-size: 0.8rem;
}

.route-option .best-for {
  margin-top: 0.75rem;
  font-size: 0.8rem;
  color: #475569;
  background: rgba(255,255,255,0.5);
  padding: 0.5rem;
  border-radius: 4px;
}

.type-grid {
  display: flex;
  flex-direction: column;
  gap: 1rem;
}

.type-option {
  display: flex;
  align-items: center;
  gap: 1rem;
  flex-wrap: wrap;
}

.type-option h5 {
  margin: 0;
  min-width: 150px;
  color: #475569;
}

.type-arrow {
  font-size: 1.5rem;
  color: #3b82f6;
}

.type-result {
  background: #dbeafe;
  padding: 0.75rem 1rem;
  border-radius: 8px;
  flex: 1;
  min-width: 200px;
}

.type-result strong {
  color: #1e40af;
}

.type-result p {
  margin: 0.25rem 0 0 0;
  font-size: 0.85rem;
  color: #475569;
}

.decision-final {
  background: linear-gradient(135deg, #dbeafe 0%, #bfdbfe 100%);
  padding: 1.5rem;
  border-radius: 12px;
  text-align: center;
  border: 2px solid #3b82f6;
}

.decision-final h4 {
  margin: 0 0 0.75rem 0;
  color: #1e40af;
  font-size: 1.2rem;
}

.decision-final p {
  margin: 0 0 0.5rem 0;
  color: #1e3a5f;
}

.annual-review {
  margin-top: 1rem !important;
  font-weight: 600;
  color: #3b82f6 !important;
}

.data-viz figcaption {
  text-align: center;
  margin-top: 1.5rem;
  font-size: 0.95rem;
  color: #475569;
  line-height: 1.6;
}

.viz-source {
  display: block;
  font-size: 0.8rem;
  color: #94a3b8;
  margin-top: 0.75rem;
  font-style: italic;
}

@media (max-width: 600px) {
  .decision-step {
    flex-direction: column;
  }
  .step-number {
    align-self: flex-start;
  }
  .route-grid, .contra-grid {
    grid-template-columns: 1fr;
  }
}
</style>
